Similar articles

• Temozolomide for refractory anaplastic astrocytoma.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1999 Dec 17;41(1068):123-4. Med Lett Drugs Ther. 1999. PMID: 10987014 No abstract available.
• Temozolomide (Temodar).

  Wesolowski JR, Rajdev P, Mukherji SK. Wesolowski JR, et al. AJNR Am J Neuroradiol. 2010 Sep;31(8):1383-4. doi: 10.3174/ajnr.A2170. Epub 2010 Jun 10. AJNR Am J Neuroradiol. 2010. PMID: 20538821 Free PMC article.
• [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].

  Zheludkova OG, Tarasova IS, Gorbatykh SV, Belogurova MB, Kumirova EV, Borodina ID, Prityko AG, Melikian AG, Shcherbenko OI. Zheludkova OG, et al. Vopr Onkol. 2002;48(3):356-60. Vopr Onkol. 2002. PMID: 12455362 Russian. No abstract available.
• Temozolomide: a novel oral alkylating agent.

  Danson SJ, Middleton MR. Danson SJ, et al. Expert Rev Anticancer Ther. 2001 Jun;1(1):13-9. doi: 10.1586/14737140.1.1.13. Expert Rev Anticancer Ther. 2001. PMID: 12113120 Review.
• [Prescription guidebook for temozolomide usage in brain tumors].

  Tilleul P, Brignone M, Hassani Y, Taillandier L, Taillibert S, Cartalat-Carel S, Borget I, Chinot O. Tilleul P, et al. Bull Cancer. 2009 May;96(5):579-89. doi: 10.1684/bdc.2009.0865. Bull Cancer. 2009. PMID: 19467988 Review. French.